Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian Cancer

Lisa Lemberger(Medical University of Vienna), Thomas W. Grunt(Comprehensive Cancer Center Vienna)

Cancers

December 5, 2022

10.3390/cancers14236004

Cited by 10

Related Papers

Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

|International Journal of Cancer|2014|62

Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells

|Oncotarget|2017|57

Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells

|Oncotarget|2018|28